Cambium Biomaterials, Inc.

CIK 1883516 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cambium Biomaterials, Inc..

Recent SEC filings

FiledFormAccession number
Dec 4, 2025D0001883516-25-000002
Nov 14, 2023D0001883516-23-000001
Sep 17, 2021D0001883516-21-000001